DevicePharm has received a Summit Marketing Effectiveness Award (MEA) for its Biom’up Hemoblast US product launch from the Summit International Awards Organization. This highly coveted international award further cements DevicePharm’s role as a leader that uses strategy and results-based effectiveness to create marketing communications solutions in today’s marketplace.
The Summit MEA recognizes and rewards companies for innovative and cutting-edge creative work. The Summit MEA is unique because it reinforces the goal of marketing communications is to change, influence, or reinforce a target audience’s knowledge, attitudes, or beliefs. Using this premise as a basis for its judging criteria, the competition is becoming a true arbiter of marketing communication effectiveness. During the 2018 event, judges analyzed submissions and selected only 3% to receive the top spots. A truly international competition, the Summit MEA received 1,482 entries from 10 countries.
“Our team’s creative brand strategy, strong marketing acumen, and innovative concepts helped create a successful product launch for our client that influenced its customers’ knowledge, attitudes, and beliefs in an effective manner,” said Jon Hermie, President of DevicePharm. “We’re honored to win this award on behalf of our client, Biom’up, and are proud that our work has earned recognition in the prestigious Summit International Awards program.”
About the Summit International Awards (SIA)
The Summit International Awards Organization, founded in 1994, is dedicated to furthering excellence in the marketing communication industry. The Summit International Awards administers three distinguished advertising and marketing award competitions throughout the year with the goal of raising the awareness of companies and individuals who have the creative and marketing talent to go beyond the ordinary. Additional information about the Summit International Awards Organization, its competitors, and winning firms can be found on the SIA website at summitawards.com.